To support women entrepreneurs in biotech, MassNextGen initiative launches

Monday, November 20, 2017

Takeda Pharmaceutical Company and the Massachusetts Life Sciences Center (MLSC) have formed a $1 million initiative aimed at supporting women entrepre­neurs in early-stage biotech with an eye toward addressing gender gaps in the life sciences sector. The five-year program, called the Massachu­setts Next Generation (MassNextGen) Initiative, provides funding and customized support, including mentoring from investors and industry executives, to empower women entrepreneurs and allow them to develop the network and skills necessary to become industry leaders.

[Read More]

Chesapeake IRB, Schulman IRB merge to create Advarra

Wednesday, November 8, 2017

Chesapeake IRB and Schulman IRB, two respected institutional review boards (IRBs), have combined to create Advarra, a premier provider of IRB, institutional biosafety committee (IBC) and research compliance services in North America. The new organization will leverage mutual strengths in technology, regulatory expertise and customer service to serve the increasingly complex needs associated with research.

[Read More]